1 |
Morena J, Gupta A, Hoyle JC. Charcot-Marie-Tooth: from molecules to therapy [J]. Int J Mol Sci, 2019, 20(14): 3419.
|
2 |
Klein CJ. Charcot-Marie-Tooth disease and other hereditary neuropathies [J]. Continuum (Minneap Minn), 2020, 26(5): 1224-1256.
|
3 |
Akdal G, Kocoglu K, Tanriverdizade T, et al. Vestibular impairment in Charcot-Marie-Tooth disease [J]. J Neurol, 2021, 268(2): 526-531.
|
4 |
Houlden H, Reilly MM, Smith S. Pupil abnormalities in 131 cases of genetically defined inherited peripheral neuropathy [J]. Eye (Lond), 2009, 23(4): 966-974.
|
5 |
Pisciotta C, Shy ME. Neuropathy [J]. Handb Clin Neurol, 2018, 148: 653-665.
|
6 |
Nagappa M, Sharma S, Taly AB. Charcot Marie Tooth [M/OL]. Germany: StatPearls Publishing, 2021.
|
7 |
Fridman V, Saporta MA. Mechanisms and treatments in demyelinating CMT [J]. Neurotherapeutics, 2021, 18(4): 2236-2268.
|
8 |
Chang EH, Mo WM, Doo HM, et al. Aminosalicylic acid reduces ER stress and Schwann cell death induced by MPZ mutations [J]. Int J Mol Med, 2019, 44(1): 125-134.
|
9 |
Werheid F, Azzedine H, Zwerenz E, et al. Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene? [J]. Brain Behav, 2016, 6(4): e451.
|
10 |
董明睿, 汪仁斌, 郝莹, 等. MPZ突变致病的腓骨肌萎缩症临床表型与基因突变相关性分析 [J]. 中日友好医院学报, 2019, 33(3): 140-143, 插1.
|
11 |
Houlden H, Laura M, Ginsberg L, et al. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy [J]. Neuromuscul Disord, 2009, 19(4): 264-269.
|
12 |
De Jonghe P, Timmerman V, Ceuterick C, et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype [J]. Brain, 1999, 122 (Pt 2): 281-290.
|
13 |
Tokuda N, Noto Y, Kitani-Morii F, et al. Parasympathetic dominant autonomic dysfunction in Charcot-Marie-Tooth disease type 2J with the MPZ Thr124Met mutation [J]. Intern Med, 2015, 54(15): 1919-1922.
|
14 |
Keltner JL, Swisher CN, Gay AJ, et al. Myotonic pupils in Charcot-Marie-Tooth disease. Successful relief of symptoms with 0.025% pilocarpine [J]. Arch Ophthalmol, 1975, 93(11): 1141-1148.
|
15 |
Baloh RH, Jen JC, Kim G, et al. Chronic cough due to Thr124Met mutation in the peripheral myelin protein zero (MPZ gene) [J]. Neurology, 2004, 62(10): 1905-1906.
|
16 |
Nakamura N, Kawamura N, Tateishi T, et al. Predominant parasympathetic involvement in a patient with Charcot-Marie-Tooth disease caused by the MPZ Thr124Met mutation [J]. Rinsho Shinkeigaku, 2009, 49(9): 582-585.
|
17 |
Misu K, Yoshihara T, Shikama Y, et al. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val) [J]. J Neurol Neurosurg Psychiatry, 2000, 69(6): 806-811.
|
18 |
Stojkovic T, de Seze J, Dubourg O, et al. Autonomic and respiratory dysfunction in Charcot-Marie-Tooth disease due to Thr124Met mutation in the myelin protein zero gene [J]. Clin Neurophysiol, 2003, 114(9): 1609-1614.
|
19 |
Houlden H, Hammans S, Katifi H, et al. A novel Frabin (FGD4) nonsense mutation p.R275X associated with phenotypic variability in CMT4H [J]. Neurology, 2009, 72(7): 617-620.
|
20 |
Chapon F, Latour P, Diraison P, et al. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene [J]. J Neurol Neurosurg Psychiatry, 1999, 66(6): 779-782.
|
21 |
Kurihara S, Adachi Y, Imai C, et al. Charcot-Marie-Tooth families in Japan with MPZ Thr124Met mutation [J]. J Neurol Neurosurg Psychiatry, 2004, 75(10): 1492-1494.
|